OptimizeRx Corp - Common Stock (OPRX)

Historical Holders from Q2 2018 to Q3 2025

Symbol
OPRX on Nasdaq
Type / Class
Equity / Common Stock
Shares outstanding
18.6M
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
13.4M
Holdings value
$274M
% of all portfolios
0.001%
Grand Portfolio weight change
+0%
Number of holders
123
Number of buys
64
Number of sells
-59
Average Value change %
+0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of OptimizeRx Corp - Common Stock (OPRX)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Whetstone Capital Advisors, LLC 8.2% 0% $13.1M 1.51M 0% Whetstone Capital Advisors, LLC 18 Apr 2025
VANGUARD GROUP INC 5.7% +14.4% $21.7M $2.81M 1.06M +14.9% The Vanguard Group 30 Sep 2025
ROYCE & ASSOCIATES LP 4.27% -25.7% $10.7M -$3.77M 791K -26.1% ROYCE & ASSOCIATES LP 30 Jun 2025
Samjo Management, LLC 0% $433 50 SAMJO MANAGEMENT, LLC 31 Dec 2024

Institutional Holders of OptimizeRx Corp - Common Stock (OPRX)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 13.4M $274M +$21.3M $20.50 123
2025 Q2 12.4M $168M +$13M $13.50 109
2025 Q1 11.7M $102M +$5.71M $8.66 87
2024 Q4 11.4M $55.3M -$15.7M $4.86 86
2024 Q3 12.4M $95.5M -$9.64M $7.72 83
2024 Q2 13.1M $131M +$5.23M $10.00 91
2024 Q1 12.8M $155M +$2.39M $12.15 97
2023 Q4 12.5M $179M -$2.15M $14.31 97
2023 Q3 13.1M $102M -$8.78M $7.78 93
2023 Q2 12.9M $184M -$7.91M $14.29 100
2023 Q1 13.4M $196M -$6.87M $14.63 107
2022 Q4 13.7M $230M +$5.84M $16.80 124
2022 Q3 13.1M $194M -$66.3M $14.82 111
2022 Q2 15.6M $428M -$2.64M $27.39 136
2022 Q1 15.5M $585M +$344K $37.71 143
2021 Q4 15M $930M +$61.4M $62.11 174
2021 Q3 13.9M $1.19B +$112M $85.55 159
2021 Q2 12.3M $761M +$45.2M $61.90 138
2021 Q1 11.4M $555M +$79.6M $48.75 117
2020 Q4 9.92M $310M +$7.61M $31.16 83
2020 Q3 9.43M $197M +$17.9M $20.85 67
2020 Q2 8.46M $110M +$12.6M $13.03 52
2020 Q1 8M $72.4M -$4M $9.06 50
2019 Q4 8.36M $85.8M +$5.16M $10.27 54
2019 Q3 7.55M $109M +$12.9M $14.48 62
2019 Q2 6.41M $104M +$32.7M $16.20 53
2019 Q1 4.51M $57.4M +$4.43M $12.72 40
2018 Q4 4.19M $45.9M +$15.9M $10.97 38
2018 Q3 2.68M $48.3M +$11.5M $18.00 29
2018 Q2 2.05M $21.3M +$21.2M $10.40 13